CIK 0002029769 · <br>Emerging growth company
Oaktree Acquisition Corp. III Life Sciences
Sign in to watch- Ticker
- OACC
- Exchange
- Nasdaq
- Industry
- Blank Checks
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 213-830-6300
- Business address
- 333 SOUTH GRAND AVENUE, 28TH FLOOR, LOS ANGELES, CA, 90071
Securities
- OACC Class A Ordinary Share Nasdaq
- OACCU Unit Nasdaq
- OACCW Warrant Nasdaq
- 8-K Event Unregistered share sale · Bylaws or fiscal year change · Shareholder vote results
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
Page 1 of 4 · 66 filings